Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Hepatogomax Improves Serum Albumin and Transaminase Enzyme Activity Levels in Sprague Dawley Rats Liver Cirrhosis

Journal of Biomedicine and Translational Research · Vol. 8 No. 3 (2022) · hlm. 112–118

DOI
10.14710/jbtr.v8i3.15078
ISSN
2503-2178
Terbit
2022-12-30
Penerbit
Faculty of Medicine, Universitas Diponegoro
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

ABSTRACTBackground: Patients with liver cirrhosis had liver cell damage and malnutrition risk. Hepatogomax enteral formula consists of soybean flour and goat’s milk flour which could reduce serum albumin, AST, and ALT levels because it contains BCAA amino acids (valine, leucine, and isoleucine) and MCT.Objective: To examine the effect of Hepatogomax enteral formula based on Soybean flour and goat’s milk flour on serum albumin, AST, and ALT levels in Sprague Dawley rats liver cirrhosis.Methods: The true experimental study – pre-post control group used 24 adult Sprague Dawley rats in 4 groups. Groups K(+), P1, and P2 were induced by Thioacetamide 400 mg/kgBW. The groups of P1 and P2 were given the Hepatogomax enteral formula made from soybean flour and goat’s milk flour at a dose of 4.87 g/200gBW and 14.6 g/200gBW for 28 days. Serum albumin levels were determined using the Bromocresol Green (BCG) method while serum AST and ALT were determined using spectrophotometry. Statistical analysis had used Paired T-Test and Kruskal Wallis test with Mann Whitney follow-up test.Results: Serum albumin, AST, and ALT levels in the P1 and P2 groups had significant differences (p<0.05) against the K(-) and K(+) groups. Enteral formula based on soybean flour and goat’s milk flour could increase serum albumin levels and reduce serum AST and ALT levels of P1 and P2 groups. The most significant improvement in serum albumin, AST, and ALT levels was at dose 14.6 g/200gBW.Conclusion: Hepatogomax enteral formula based on Soybean flour and goat’s milk flour could increase serum albumin and redue AST, and ALT levels Sprague Dawley rats liver cirrhosis.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 194 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Institut Teknologi Kalimantan
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Gemala AnjaniAfiliasi tidak diketahui7
Faizah FulyaniAfiliasi tidak diketahui6
Fillah Fithra DienyAfiliasi tidak diketahui5
Muflihatul MunirohAfiliasi tidak diketahui4
Nani MaharaniAfiliasi tidak diketahui4
Diana Nur AfifahAfiliasi tidak diketahui3
A Fahmy Arif TsaniAfiliasi tidak diketahui2
Agung PrasetyoAfiliasi tidak diketahui2
Didik IndiarsoAfiliasi tidak diketahui2
Hirlan HirlanAfiliasi tidak diketahui2
Siti Fatimah MuisAfiliasi tidak diketahui2
Miftahul adnanAfiliasi tidak diketahui1
Hardhono SusantoAfiliasi tidak diketahui1
Sumardi WidodoAfiliasi tidak diketahui1
Karinda Kennia AntikaAfiliasi tidak diketahui1
Kartika NugraheniInstitut Teknologi Kalimantan1
Widya Hary CahyatiAfiliasi tidak diketahui1
Alfiana Ainun NisaAfiliasi tidak diketahui1
Natalia Desy PutriningtyasAfiliasi tidak diketahui1
Rini R BachtiarAfiliasi tidak diketahui1
Juferdy KurniawanAfiliasi tidak diketahui1
Fauzi YusufAfiliasi tidak diketahui1
Syifa MustikaAfiliasi tidak diketahui1
Nenny AgustantiAfiliasi tidak diketahui1
Ulfa KholiliAfiliasi tidak diketahui1
Gita ApriliciaAfiliasi tidak diketahui1
Cecilia O PermatawediAfiliasi tidak diketahui1
Tehar Karo-KaroAfiliasi tidak diketahui1
Haris WiditaAfiliasi tidak diketahui1
Aritantri DarmayaniAfiliasi tidak diketahui1
Arif Nur WidodoAfiliasi tidak diketahui1
Saptino MiroAfiliasi tidak diketahui1
Suyata SuyataAfiliasi tidak diketahui1
Catharina TriwikatmaniAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ejournal2.undip.ac.id/index.php/jbtr/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 9 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Hepatogomax Improves Serum Albumin and Transaminase Enzyme Activity Levels in Sprague Dawley Rats Liver Cirrhosis</dc:title>
	<dc:creator>Kusuma, Refani Alycia</dc:creator>
	<dc:creator>Noer, Etika Ratna</dc:creator>
	<dc:creator>Purnomo, Hery Djagat</dc:creator>
	<dc:creator>Pramono, Adriyan</dc:creator>
	<dc:creator>Mahati, Endang</dc:creator>
	<dc:creator>Nissa, Choirun</dc:creator>
	<dc:subject xml:lang="en-US">Liver Cirrhosis; Hepatogomax; Albumin; Transaminase Enzyme Activity</dc:subject>
	<dc:description xml:lang="en-US">ABSTRACTBackground: Patients with liver cirrhosis had liver cell damage and malnutrition risk. Hepatogomax enteral formula consists of soybean flour and goat’s milk flour which could reduce serum albumin, AST, and ALT levels because it contains BCAA amino acids (valine, leucine, and isoleucine) and MCT.Objective: To examine the effect of Hepatogomax enteral formula based on Soybean flour and goat’s milk flour on serum albumin, AST, and ALT levels in Sprague Dawley rats liver cirrhosis.Methods: The true experimental study – pre-post control group used 24 adult Sprague Dawley rats in 4 groups. Groups K(+), P1, and P2 were induced by Thioacetamide 400 mg/kgBW. The groups of  P1 and P2 were given the Hepatogomax enteral formula made from soybean flour and goat’s milk flour at a dose of 4.87 g/200gBW and 14.6 g/200gBW for 28 days. Serum albumin levels were determined using the Bromocresol Green (BCG) method while serum AST and ALT were determined using spectrophotometry. Statistical analysis had used Paired T-Test and Kruskal Wallis test with Mann Whitney follow-up test.Results: Serum albumin, AST, and ALT levels in the P1 and P2 groups had significant differences (p&lt;0.05) against the K(-) and K(+) groups. Enteral formula based on soybean flour and goat’s milk flour could increase serum albumin levels and reduce serum AST and ALT levels of P1 and P2 groups. The most significant improvement in serum albumin, AST, and ALT levels was at dose 14.6 g/200gBW.Conclusion: Hepatogomax enteral formula based on Soybean flour and goat’s milk flour could increase serum albumin and redue AST, and ALT levels Sprague Dawley rats liver cirrhosis.</dc:description>
	<dc:publisher xml:lang="en-US">Faculty of Medicine, Universitas Diponegoro</dc:publisher>
	<dc:date>2022-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/15078</dc:identifier>
	<dc:identifier>10.14710/jbtr.v8i3.15078</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Biomedicine and Translational Research; Vol 8, No 3 (2022): December 2022; 112-118</dc:source>
	<dc:source>2503-2178</dc:source>
	<dc:source>10.14710/jbtr.v8i3</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/15078/8427</dc:relation>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/15078/3617</dc:relation>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/15078/3618</dc:relation>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/15078/3917</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Journal of Biomedicine and Translational Research</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>